| __timestamp | Amicus Therapeutics, Inc. | CymaBay Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 8185000 |
| Thursday, January 1, 2015 | 47269000 | 8871000 |
| Friday, January 1, 2016 | 71151000 | 9645000 |
| Sunday, January 1, 2017 | 88671000 | 12387000 |
| Monday, January 1, 2018 | 127200000 | 14381000 |
| Tuesday, January 1, 2019 | 169861000 | 19238000 |
| Wednesday, January 1, 2020 | 156407000 | 17425000 |
| Friday, January 1, 2021 | 192710000 | 23040000 |
| Saturday, January 1, 2022 | 213041000 | 25116000 |
| Sunday, January 1, 2023 | 275270000 | 51953000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, understanding financial trends is crucial. Over the past decade, Amicus Therapeutics, Inc. and CymaBay Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amicus Therapeutics experienced a staggering 1,230% increase in SG&A expenses, reflecting its aggressive expansion and operational scaling. In contrast, CymaBay Therapeutics saw a more modest 535% rise, indicating a more conservative growth strategy.
By 2023, Amicus's SG&A expenses were approximately five times higher than CymaBay's, highlighting its larger market footprint. This divergence underscores the different strategic priorities of these companies, with Amicus focusing on rapid growth and CymaBay maintaining a steady course. Investors and industry analysts should consider these trends when evaluating the financial health and strategic direction of these biotech firms.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Amgen Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Genmab A/S or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Catalent, Inc. and CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for TG Therapeutics, Inc. and Amicus Therapeutics, Inc.
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights
Perrigo Company plc or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.